The audited financial results (standalone and consolidated) for the quarter and year ended 31.03.2025 have been approved by the Board of Directors meeting today, 29.05.2025.
BCPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved audited results for the quarter and year ended March 31, 2025 on May 29, 2025. Standalone revenue from operations rose about 50% YoY to ₹13,195.70 lakhs (FY24: ₹8,793.39 lakhs), while standalone PAT grew roughly 50% to ₹828.58 lakhs (FY24: ₹552.19 lakhs), pushing EPS to ₹4.95 vs ₹3.30. On a consolidated basis, revenue jumped about 83% to ₹16,085.66 lakhs, but consolidated PAT slipped marginally to ₹505.92 lakhs (FY24: ₹535.70 lakhs) because subsidiary BCL Bio Energy posted a loss of about ₹313 lakhs for the year, and consolidated operating cash flow turned more negative at ₹(576.87) lakhs. The Board recommended a final dividend of ₹1 (10%) per share with record date June 13, 2025, and approved disinvestment of a 22% stake in BCL Bio Energy, reducing its holding to 29%. Statutory auditor L B Jha & Co. issued an unmodified (clean) opinion on both standalone and consolidated results.
Positive for shareholders on the back of strong standalone revenue and profit growth and a steady 10% dividend, though the consolidated picture is clouded by losses and cash burn in the bio-energy subsidiary; the planned partial exit from that subsidiary should be read as a positive cleanup move.